The HOLiFOOD consortium is reimagining food safety risk assessment for the benefit of all stakeholders in the food chain ...

BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% ...

ZYUS Life Sciences Corporation (the "Company") , a clinical-stage life sciences company focused on the development and ...

GLP-1 medications are prescription treatments that require evaluation by a licensed clinician. Compounded medications are not FDA-approved as finished products. Always consult a qualified healthcare ...

Liquidia Corporation remains a Buy for risk-tolerant biotech investors, supported by strong Yutrepia launch metrics and ...

Bright Minds Biosciences (DRUG) stays a Strong Buy after Phase 2 BMB-101 seizure-reduction data; see 2026 catalysts, ...

MetaVia will now be investigating the candidate at two different titration levels in 16-week trials for obesity.

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...

Back in 1934, Ralph Nelson Elliott discovered that price action displayed on charts, instead of behaving in a somewhat chaotic manner, had actually an intrinsic narrative attached. Elliot saw the same ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

An in-depth analysis of nutrient availability across mouse tissues reveals their influence on the spread of cancer to other organs. Measurements of the masses of exoplanets orbiting a young star have ...